FDA: Two die after taking Genentech, Biogen drug - Dec. 18, 2006
Rituxan, authorized for lymphoma and rheumatoid arthritis, is not approved
for treating lupus but doctors sometimes prescribe it for that use, the Food
and Drug Administration said in a notice posted on its Web site.
http://money.cnn.com/2006/12/18/news/companies/bc.genentech.rituxan.reut/index.htm?section=money_email_alerts
Rituxan, authorized for lymphoma and rheumatoid arthritis, is not approved
for treating lupus but doctors sometimes prescribe it for that use, the Food
and Drug Administration said in a notice posted on its Web site.
http://money.cnn.com/2006/12/18/news/companies/bc.genentech.rituxan.reut/index.htm?section=money_email_alerts
0 Comments:
Post a Comment
<< Home